From the Department of Organ Transplantation and General Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Exp Clin Transplant. 2021 Dec;19(12):1348-1351. doi: 10.6002/ect.2021.0306. Epub 2021 Nov 10.
Ogilvie syndrome (acute colonic pseudo-obstruction) is a rare, acquired, life-threatening disorder for which treatment plans vary from simple observation to surgical intervention. Ogilvie syndrome has been reported in patients after renal or liver transplant, but its occurrence after simultaneous pancreas-kidney transplant is rare. Herein, we present the case of a 45-year-old female recipient of a deceased donor simultaneous pancreas-kidney transplant who developed Ogilvie syndrome 10 days after a previous fecal ileus that had resolved at posttransplant week 3. She demonstrated Ogilvie syndrome with obstructive colitis features (severe abdominal pain and high-grade fever), which we immediately treated with colonic decompensation by placement of a transanal ileus tube. After several screening examinations and discontinuation of unnecessary medicines, we were not able to confirm the cause of Ogilvie syndrome in our patient. After 2 weeks, the patient remained unresponsive to the conservative treatment, and so hand-assisted laparoscopic subtotal colectomy was performed to remove the dilated colon. Her symptoms gradually resolved after surgery. Histologically, we confirmed submucosal fibrotic changes, especially at the distal end of the resected colon, without evidence of amyloidosis, and the number of Auerbach plexus ganglia had decreased. Nevertheless, we observed no degenerated appearance of ganglion cells in the Auerbach plexus or the Meissner plexus. After exclusion of several collagen diseases, including systemic sclerosis, we determined that idiopathic colonic fibrosis was the likely cause of Ogilvie syndrome in our patient. When surgery is indicated in transplant patients with Ogilvie syndrome with obstructive colitis features, colectomy should be considered.
奥格尔维氏综合征(急性结肠假性梗阻)是一种罕见的、获得性的、危及生命的疾病,其治疗方案从简单的观察到手术干预不等。奥格尔维氏综合征已在肾或肝移植后的患者中报告,但在同时胰腺-肾移植后发生则较为罕见。在此,我们报告了一位 45 岁女性接受了已故供体同时胰腺-肾移植,在移植后第 3 周解决了先前的粪便性肠梗阻后 10 天发生奥格尔维氏综合征。她表现出奥格尔维氏综合征伴有梗阻性结肠炎特征(严重腹痛和高热),我们立即通过经肛门肠梗阻管放置来进行结肠减压治疗。在进行了多次筛查检查和停用不必要的药物后,我们无法确定患者奥格尔维氏综合征的原因。2 周后,患者对保守治疗仍无反应,因此进行了手辅助腹腔镜次全结肠切除术以切除扩张的结肠。手术后,她的症状逐渐缓解。组织学上,我们确认了黏膜下纤维化改变,特别是在切除结肠的远端,没有淀粉样变性的证据,并且 Auerbach 神经丛的神经节数量减少。然而,我们没有观察到 Auerbach 神经丛或 Meissner 神经丛中神经节细胞的退行性外观。在排除了几种胶原病,包括系统性硬化症后,我们确定特发性结肠纤维化是患者奥格尔维氏综合征的可能原因。当有奥格尔维氏综合征伴梗阻性结肠炎特征的移植患者需要手术时,应考虑结肠切除术。